MAGE-A3, MAGE-A4, cyclin D, cyclin E, cyclin A and cyclin B mRNA expression levels in tumor samples categorized by Brigham and Women’s Hospital Tumor Staging System and tumor differentiation are shown in Fig 1. This evidence concerns the gene MAGEA4 and neoplasm.